[HTML][HTML] Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
DJ Drucker - Cell metabolism, 2021 - cell.com
The increased prevalence of obesity, diabetes, and cardiovascular risk factors in people
hospitalized with severe COVID-19 illness has engendered considerable interest in the …
hospitalized with severe COVID-19 illness has engendered considerable interest in the …
Impact of diabetes in patients diagnosed with COVID-19
COVID-19 is a disease caused by the coronavirus SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus-2), known as a highly contagious disease, currently affecting more …
Syndrome Coronavirus-2), known as a highly contagious disease, currently affecting more …
Previous COVID-19 infection and antibody levels after vaccination
Background: The emergence of new COVID-19 variants of concern coupled with a global
inequity in vaccine access and distribution has prompted many public health authorities to …
inequity in vaccine access and distribution has prompted many public health authorities to …
Robust antibody levels in both diabetic and non-diabetic individuals after BNT162b2 mRNA COVID-19 vaccination
The emergence of effective vaccines for COVID-19 has been welcomed by the world with
great optimism. Given their increased susceptibility to COVID-19, the question arises …
great optimism. Given their increased susceptibility to COVID-19, the question arises …
Therapeutic potential of metformin in COVID-19: reasoning for its protective role
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections present with
increased disease severity and poor clinical outcomes in diabetic patients compared with …
increased disease severity and poor clinical outcomes in diabetic patients compared with …
Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait
This is a retrospective single-center study of 417 consecutive patients with coronavirus
disease 2019 (COVID-19) admitted to Jaber Al-Ahmad Hospital in Kuwait between February …
disease 2019 (COVID-19) admitted to Jaber Al-Ahmad Hospital in Kuwait between February …
Insulin treatment may increase adverse outcomes in patients with COVID-19 and diabetes: a systematic review and meta-analysis
Y Yang, Z Cai, J Zhang - Frontiers in Endocrinology, 2021 - frontiersin.org
Background and Objective Recently, insulin treatment has been found to be associated with
increased mortality and other adverse outcomes in patients with coronavirus disease 2019 …
increased mortality and other adverse outcomes in patients with coronavirus disease 2019 …
Cellular and humoral immune responses in covid-19 and immunotherapeutic approaches
A Hasan, E Al-Ozairi, Z Al-Baqsumi… - ImmunoTargets and …, 2021 - Taylor & Francis
Abstract Coronavirus disease 2019 (Covid-19), caused by the novel coronavirus severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can range in severity from …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can range in severity from …
Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization
J Kesavadev, A Misra, B Saboo, SR Aravind… - Diabetes & Metabolic …, 2021 - Elsevier
Background and aims The measurement of vital signs is an important part of clinical work
up. Presently, measurement of blood glucose is a factor for concern mostly when treating …
up. Presently, measurement of blood glucose is a factor for concern mostly when treating …
High admission blood glucose independently predicts poor prognosis in COVID-19 patients: a systematic review and dose-response meta-analysis
G Lazarus, J Audrey, VK Wangsaputra… - diabetes research and …, 2021 - Elsevier
Aims To investigate the prognostic value of admission blood glucose (BG) in predicting
COVID-19 outcomes, including poor composite outcomes (mortality/severity), mortality, and …
COVID-19 outcomes, including poor composite outcomes (mortality/severity), mortality, and …